CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED

Clinical trials for CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED explained in plain language.

Never miss a new study

Get alerted when new CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED trials appear

Sign up with your email to follow new studies for CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for patients with rare, Hard-to-Treat blood disorders

Disease control Recruiting now

This study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …

Matched conditions: CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED

Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED

Get alerted when new CHRONIC EOSINOPHILIC LEUKEMIA, NOT OTHERWISE SPECIFIED trials appear

New hope for patients with rare, Hard-to-Treat blood disorders